The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

The mother is accused of lying about her child’s medical condition while also reportedly not refilling medication that had been prescribed to her daughter.

Jeff Bezos’s $10 billion climate and biodiversity fund has halted its funding of one of the world’s most important climate ...